Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 312.40
Bid: 311.80
Ask: 312.40
Change: 0.20 (0.06%)
Spread: 0.60 (0.192%)
Open: 310.20
High: 312.60
Low: 308.20
Prev. Close: 312.20
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Mar 2016 10:51

RNS Number : 8950S
Ascential PLC
22 March 2016
 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Grant of Awards under the Company's Performance Share Plan.

 

On 21 March 2016 the Company's Executive Directors were granted nil cost option awards over ordinary shares of 10p each under the Ascential plc Executive Performance Share Plan (the "PSP") as noted below:

 

Executive Director

Number of Shares under Award

Duncan Painter

402,500

Mandy Gradden

236,250

 

Subject to the terms of the PSP, the awards will ordinarily vest and become exercisable as from the third anniversary of the grant of the awards subject to the grantee's continued service and to the extent to which cumulative adjusted EBITA and relative total shareholder return performance criteria are met over their respective measurement periods.

 

The measurement period for the adjusted EBITA measure comprises three financial years of the Company ending on 31 December 2018.

 

The measurement period for total shareholder return measure comprises the period commenced on the date of the Company's admission to trading in February 2016 and ending on 31 December 2018.

 

Once exercisable, an award shall ordinarily remain exercisable until the eve of the tenth anniversary of the grant date of the awards.

 

No consideration was paid for the grant of the awards and no consideration is due on the vesting and/or exercise of the awards.

 

The Company was notified of the above transactions on 21 March 2016.

 

The transactions took place in the United Kingdom.

 

This notification is made in accordance with DTR 3.1.4(1)(a).

 

For further information please contact:

 

Mandy Gradden, Chief Financial Officer

020 7516 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAEDAALNKEFF
Date   Source Headline
9th May 202411:37 amRNSResult of AGM
8th May 20246:00 pmRNSAscential
8th May 20247:00 amRNSTender Offer Results and Special Dividend
2nd May 20242:41 pmRNSHolding(s) in Company
1st May 20244:07 pmRNSHolding(s) in Company
1st May 20241:21 pmRNSHolding(s) in Company
1st May 20241:15 pmRNSTotal Voting Rights
22nd Apr 20243:39 pmRNSResults of General Meeting
18th Apr 20246:14 pmRNSDirector/PDMR Shareholding
11th Apr 202410:12 amRNSHolding(s) in Company
10th Apr 20241:48 pmRNSHolding(s) in Company
10th Apr 202410:32 amRNSNotice of AGM
9th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 20245:09 pmRNSHolding(s) in Company
5th Apr 20243:18 pmRNSHolding(s) in Company
4th Apr 20241:45 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSProposed Return of Value of £850m to Shareholders
3rd Apr 202410:39 amRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSHolding(s) in Company
2nd Apr 202412:00 pmRNSTotal Voting Rights
28th Mar 20242:25 pmRNSHolding(s) in Company
28th Mar 202411:33 amRNSHolding(s) in Company
27th Mar 202412:02 pmRNSHolding(s) in Company
26th Mar 202412:16 pmRNSHolding(s) in Company
25th Mar 20243:40 pmRNSHolding(s) in Company
25th Mar 20242:26 pmRNSHolding(s) in Company
22nd Mar 20242:20 pmRNSHolding(s) in Company
21st Mar 20243:38 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSUnaudited full year results 2023
13th Mar 20244:49 pmRNSHolding(s) in Company
12th Mar 20241:24 pmRNSHolding(s) in Company
1st Mar 20242:25 pmRNSTotal Voting Rights
29th Feb 202410:22 amRNSHolding(s) in Company - Correction
27th Feb 20241:12 pmRNSHolding(s) in Company
22nd Feb 20245:01 pmRNSHolding(s) in Company
20th Feb 20241:26 pmRNSHolding(s) in Company
16th Feb 20241:06 pmRNSHolding(s) in Company
15th Feb 20244:08 pmRNSHolding(s) in Company
7th Feb 20243:40 pmRNSHolding(s) in Company
6th Feb 20244:06 pmRNSTotal Voting Rights
6th Feb 20241:41 pmRNSHolding(s) in Company
5th Feb 20241:05 pmRNSHolding(s) in Company
1st Feb 20242:48 pmRNSCompany Secretary Change
1st Feb 202411:35 amRNSCompletion of the sale of WGSN
5th Jan 20242:52 pmRNSBlock listing Interim Review
5th Jan 20247:49 amRNSDirector/PDMR Shareholding
4th Jan 202412:53 pmRNSHolding(s) in Company
2nd Jan 202411:21 amRNSUpdate on Sale Processes, Governance and Financing
29th Dec 202310:00 amRNSDirector/PDMR Shareholding
18th Dec 202310:10 amRNSResults of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.